World's Best Scientists 2026 revealed!
Jonas A. Nilsson

Jonas A. Nilsson

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
30085
World Ranking
8937
National Ranking
121

Overview

Jonas A. Nilsson is affiliated with the University of Gothenburg in Sweden and has made contributions primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research encompasses multiple subfields, notably Molecular Biology, Oncology, Immunology, Ophthalmology, and Genetics.

The scientist's research topics span diverse areas including Ocular Oncology and Treatments, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research, as well as Microtubule and mitosis dynamics.

Their recent publication record includes the following papers:

  • The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma (2021), Nature Communications
  • Molecular profiling of driver events in metastatic uveal melanoma (2020), Nature Communications
  • SUMO pathway inhibition targets an aggressive pancreatic cancer subtype (2020), Gut
  • Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial) (2023), Journal of Clinical Oncology
  • Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models (2020), Annals of Oncology

Jonas A. Nilsson frequently collaborates with several researchers, including Lars Ny, Roger Olofsson Bagge, Lisa M. Nilsson, Joakim Karlsson, and Hildur Helgadóttir.

Their work has appeared in a variety of scientific venues, with the most frequent publication platforms being bioRxiv (Cold Spring Harbor Laboratory), Journal of Clinical Oncology, Cancers, eLife, and Nature Communications.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors

    Su Chul Jang;Oh Youn Kim;Chang Min Yoon;Dong-Sic Choi

  • Antioxidants accelerate lung cancer progression in mice.

    Volkan I. Sayin;Mohamed X. Ibrahim;Erik Larsson;Jonas A. Nilsson

  • DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity.

    Anetta Härtlova;Saskia F. Erttmann;Faizal Am. Raffi;Anja M. Schmalz

  • Antioxidants can increase melanoma metastasis in mice

    Kristell Le Gal;Mohamed X. Ibrahim;Clotilde Wiel;Volkan I. Sayin

  • Myc pathways provoking cell suicide and cancer

    Jonas A Nilsson;John L Cleveland

  • c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression

    Troy A. Baudino;Catriona McKay;Helene Pendeville-Samain;Jonas A. Nilsson

  • Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

    Michael T. Hemann;Anka Bric;Julie Teruya-Feldstein;Andreas Herbst

  • MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

    Helge Gad;Tobias Koolmeister;Ann-Sofie Jemth;Saeed Eshtad

  • Investment with a Conscience: Examining the Impact of Pro-Social Attitudes and Perceived Financial Performance on Socially Responsible Investment Behavior

    Jonas Nilsson

  • Enrichment of glycopeptides for glycan structure and attachment site identification.

    Jonas Nilsson;Ulla Rüetschi;Adnan Halim;Camilla Hesse

  • Commitment to Sustainability in Small and Medium-Sized Enterprises: The Influence of Strategic Orientations and Management Values

    Johan Jansson;Jonas Nilsson;Frida Modig;Gabriella Hed Vall

  • Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401.

    Minna Tanner;Jorma Isola;Tom Wiklund;Björn Erikstein

  • Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types

    Nils Johan Fredriksson;Lars Ny;Jonas A. Nilsson;Erik Larsson

  • Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid

    Adnan Halim;Gunnar Brinkmalm;Ulla Rüetschi;Ann Westman-Brinkmalm

  • Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

    Jonas Bergh;Tom Wiklund;Björn Erikstein;Elisabet Lidbrink

  • Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

    Jürgen den Hollander;Sara Rimpi;Joanne R. Doherty;Martina Rudelius

  • Segmenting socially responsible mutual fund investors: The influence of financial return and social responsibility

    Jonas Nilsson

  • BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma

    Joydeep Bhadury;Lisa M. Nilsson;Somsundar Veppil Muralidharan;Lydia C. Green

  • Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.

    Claudio Praga;Jonas Bergh;Judith Bliss;Jacques Bonneterre

Frequent Co-Authors

Göran Larson
Göran Larson University of Gothenburg
John L. Cleveland
John L. Cleveland Moffitt Cancer Center
Jan Lötvall
Jan Lötvall University of Gothenburg
Yong Song Gho
Yong Song Gho Pohang University of Science and Technology
Christian Peschel
Christian Peschel Technical University of Munich
Nicolle H. Packer
Nicolle H. Packer Macquarie University
Ola Nilsson
Ola Nilsson Karolinska Institute
Andrew F. Hill
Andrew F. Hill Victoria University
Daniel Kolarich
Daniel Kolarich Griffith University
Kaj Blennow
Kaj Blennow University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens up a range of online study options that can greatly expand your career opportunities. Whether you're interested in healthcare, research, or nutrition, online programs offer flexible learning paths to match your goals.

Those wanting a fast-track into the medical field may consider a ma to lpn bridge program online, which allows medical assistants to advance their qualifications and scope of practice. If your passion lies in life sciences more broadly, you could pursue one of many online biology degree programs for a flexible path to lab work or biotechnology.

For those drawn to patient care, accredited online nursing programs offer training in clinical skills and healthcare theory, with pathways to a variety of clinical roles. Alternatively, if nutrition and wellness inspire you, there are excellent online nutrition degrees that prepare graduates for careers in dietetics, wellness coaching, and nutrition research.

These diverse online degrees are ideal for students seeking flexibility, career advancement, and options tailored to roles in the health and science sectors.

Best Scientists Citing Jonas A. Nilsson

Trending Scientists

Recently Published Articles